ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
27 announcements
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new US-based subsidiary, Fineotex America Inc., for ₹0.05 Crore to provide specialized water treatment solutions.
Fineotex Chemical's FZE subsidiary incorporated Fineotex America Inc. in Delaware, USA. The entity will supply water treatment chemicals for data centers and semiconductors.
Fineotex Chemical Limited conducted its 23rd Annual General Meeting on September 11, 2026. Shareholders discussed ordinary and special business items, including dividend and fund raising proposals.
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new wholly-owned subsidiary, Fineotex Holdings Inc., in the USA for specialty chemical business activities.
Fineotex Chemical Limited incorporated a new wholly-owned step-down subsidiary, Fineotex Holdings Inc., in the USA. This entity will pursue specialty chemical and growth opportunities.
Fineotex Chemical Limited announced an upgrade in its long-term credit rating to [ICRA]AA- (Stable) by ICRA, while reaffirming its short-term rating at [ICRA]A1+.
Fineotex Chemical Ltd has filed its Business Responsibility and Sustainability Report for the financial year 2025-26, as mandated by SEBI regulations for listed entities.
Fineotex Chemical Limited has filed its Annual Report for the financial year 2025-26. The 23rd Annual General Meeting is scheduled for September 11, 2026.
Fineotex Chemical Limited has set September 04, 2026, as the record and cut-off date for its 23rd AGM. The meeting is scheduled for September 11, 2026.
Fineotex Chemical Limited has received board approval to raise funds. The company has fixed September 11, 2026, for the subsequent shareholder meeting regarding this proposal.
Fineotex Chemical announced its 23rd AGM for September 11, 2026, with a record date of September 4, 2026. The Board also approved a proposal to raise funds.
Fineotex Chemical will hold a board meeting on August 17, 2026, to consider a proposal for raising funds through various equity-based instruments.
Fineotex delivered a massive 165% revenue surge driven by the full consolidation of its US-based oil and gas subsidiary, CrudeChem. Management is aggressively pivoting from textiles toward high-margin US energy markets.
Fineotex Chemical reported Q1 FY27 total income of ₹386.7 crore, up 164% YoY. The company also commissioned a major capacity expansion at its Texas facility.
Fineotex (FCL) presents its Q1 FY27 performance, highlighting its evolution into a diversified specialty chemical powerhouse with significant expansion into the US oil and gas sector through CrudeChem.
Fineotex Chemical Limited reported its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following its board meeting held on July 23, 2026.
Fineotex Chemical will hold a board meeting on July 23, 2026. The board will consider and approve Q1 2026 unaudited financial results.
Fineotex Chemical's US subsidiary CrudeChem Technology is expanding its Texas manufacturing capacity by 150 million pounds annually. This strategic move supports growing global demand for specialty chemicals.
Fineotex Chemical Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no new material deviations.
Fineotex Chemical reports 162% revenue growth to ₹314cr in Q4FY26, driven by the CrudeChem acquisition and strong specialty textile chemical demand.
Fineotex Chemical delivered explosive growth in Q4 FY26, driven by the strategic acquisition of US-based CCT Group. Management is pivoting from textile chemicals to a high-margin global oil and gas platform.
Fineotex (FCL) released its Q4 FY26 investor presentation highlighting a diversified portfolio across Textile, Oil & Gas, and Cleaning & Hygiene, with a significant recent acquisition of US-based CrudeChem Technologies.
Fineotex Chemical Limited (FCL) presents its Q4 FY26 investor update, focusing on its diversification into oil & gas chemicals and expanding global manufacturing capacity to 2,00,000 MTPA.
Fineotex Chemical reported FY26 consolidated revenue of ₹772.23 Crore, up 45% YoY. Strong growth was driven by successful integration of its US oilfield chemicals business.
Fineotex Chemical scheduled a May 15, 2026 board meeting to approve audited financial results. Directors will also consider a final dividend recommendation for shareholders.
Fineotex Chemical Limited submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the period ended March 31, 2026. The Registrar, Bigshare Services, confirmed that security certificates received for dematerialization were processed and listed on the exchanges within the stipulated 15-day timeline.
Fineotex Chemical Ltd reported net profit of ₹30.1 Cr (+8.3% YoY) for Q3 FY26.